19.59
Silence Therapeutics Plc Adr Azioni (SLN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
100.00%
-
|
0.422 | 0.034 | 0.159 | 0.224 |
| Cost Of Revenue |
100.00%
-
|
0.011 | 0.012 | 0.064 | 0.085 |
| Gross Profit |
100.00%
-
|
0.411 | 0.022 | 0.095 | 0.139 |
| Research and Development |
0.29%
9.148
|
9.122 | - | - | - |
| Operating Income/Loss |
11.90%
-13.87
|
-15.74 | -12.46 | -26.24 | -23.96 |
| Income/Loss From Continuing Operations Before Tax |
17.98%
-12.27
|
-14.96 | -11.77 | -20.96 | -27.34 |
| Income Tax Expense/Benefit |
0.001
|
- | - | 0.001 | 0.01 |
| Net Income/Loss |
17.98%
-12.27
|
-14.96 | -11.77 | -20.96 | -27.35 |
| Basic Average Shares |
0.01%
141.71
|
141.70 | 0.00241 | 141.70 | 141.70 |
| Diluted Average Shares |
0.01%
141.71
|
141.70 | 0.00241 | 141.70 | 141.70 |
| Basic Earnings Per Share |
18.18%
-0.09
|
-0.11 | -0.09 | -0.15 | -0.19 |
| Diluted Earnings Per Share |
18.18%
-0.09
|
-0.11 | -0.09 | -0.15 | -0.19 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):